Hepatic oxidative DNA damage is associated with increased risk for hepatocellular carcinoma in chronic hepatitis C

by Tanaka, H, Fujita, N, Sugimoto, R, Urawa, N, Horiike, S, Kobayashi, Y, Iwasa, M, Ma, N, Kawanishi, S, Watanabe, S, Kaito, M, Takei, Y
Published 2008

Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial

by Ikeda, M., Shimizu, S., Sato, T., Morimoto, M., Kojima, Y., Inaba, Y., Hagihara, A., Kudo, M., Nakamori, S., Kaneko, S., Sugimoto, R., Tahara, T., Ohmura, T., Yasui, K., Sato, K., Ishii, H., Furuse, J., Okusaka, T.
Published 2016